Monday, 10 March 2014

Market Overview-China Chinese Patent Medicine Industry Report, 2013 - 2016 -Market Growth, Trends, and Forecast

New Market Research Report Added in MarketResearchReports.Biz Reports Database: China Chinese Patent Medicine Industry Report, 2013 - 2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance with specified prescription and standard. Chinese patent medicine industry covers the upstream Chinese herbal medicine production and preliminary processing, the middle pharmaceutical sectors as well as downstream commercial institutions of drug circulation and sales.

Browse Complete report with TOC : 

Currently, the State is enhancing its support for the Chinese patent medicine industry, successively introducing the Continuing Improving TCM Healthcare Policy, Notice on Conducting Construction of Key Projects of TCM Trade in Services and other favorable policies in 2013. In 2010-2013, China’s Chinese patent medicine industry developed rapidly, with revenue soaring from RMB215.4 billion to RMB448.2 billion at a CAGR of 27.7%.

According to hospital terminal data, Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases and respiratory system diseases are the top three categories of Chinese patent medicine in China, respectively accounting for 37.2%, 15.4% and 11.1% market share in 2012-2013. As far as the distribution of Chinese patent medicine formulations is concerned, there is a clear trend of convergence in injection, and injection formulation products in the top three categories of Chinese patent medicine all made up above 50%.

Cardiovascular and cerebrovascular disease market is the biggest market for Chinese patent medicine, but also the most-variety field with item sales of over RMB500 million. The representative products include ginkgo leaf injection, Shuxuetong injection, Danhong injection, Xingnao injection, and more.

To Download Sample Report Visit : 

In the international market, there is a higher recognition of Chinese patent medicine in Asia, especially in Southeast Asia, and many varieties of Chinese patent medicine are included in the Medicare drug list stipulated by Southeast Asian countries, and special departments are established for management research as well. But in the U.S. and European markets, affected by access restrictions and differences in medical health concept, Chinese patent medicine is still only sold as health care product. However, the international market sees strong demand for plant extracts (mostly traditional Chinese medicinal materials) whose export value in 2010-2013 grew at a CAGR of 44% and accounted for approximately 50% of China’s TCM export value.

Table of Content

1. Overview of Chinese Patent Medicine
1.1 Definition and Characteristics
1.2 Classification
1.2.1 Classification by Dosage Form
1.2.2 Classification by Pharmacology
1.2.3 Industry Chain

2. Operating Environment for Chinese Patent Medicine Industry
2.1 Policies
2.1.1 Domestic Policies
2.1.2 Foreign Policies
2.2 Consumer Trends
2.3 Industry Trends

3. Chinese Patent Medicine Market
3.1 Development Status
3.2 Demand
3.2.1 Regional Demand
3.2.2 Product Demand Structure
3.2.3 Trends
3.3 Supply
3.3.1 Yield Analysis and Key Areas
3.3.2 Industry Concentration
3.4 Regional Analysis of Players
3.5 Import and Export
3.5.1 Import
3.5.2 Export
3.5.3 Import-Export Structure
3.6 Traditional Chinese Medicinal Materials
3.6.1 Resources
3.6.2 Price Trend

Visit Report  Analysis: 

4. Chinese Patent Medicine Market Segments in China
4.1 Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
4.2 Chinese Patent Medicine for Tumor Diseases
4.3 Chinese Patent Medicine for Respiratory System Diseases
4.4 Chinese Patent Medicine for Musculoskeletal Diseases

5. Key Enterprises
5.1 Tianjin Tasly Pharmaceutical Co., Ltd.
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Prospects
5.2 Guizhou Yibai Pharmaceutical Co., Ltd.
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 Prospects
5.3 Yunnan Baiyao Group Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 Prospects
5.4 Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Prospects
5.5 Shandong Dong-E E-Jiao Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Prospects
5.6 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu)
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure

6. Summary and Forecast
6.1 Comparison of Domestic Key Chinese Patent Medicine Enterprises
6.1.1 Revenue
6.1.2 Gross Margin
6.2 Industry Forecast
6.2.1 Industry Trends
6.2.2 Market Forecast

About Us is the most comprehensive collection of market research reports. services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve
all sizes and types of companies spanning across various industries.

Contact US:  

Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030


No comments:

Post a Comment